Antifungal activity of redox-active benzaldehydes that target cellular antioxidation
Background: Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of c...
Saved in:
Published in | Annals of clinical microbiology and antimicrobials Vol. 10; no. 1; p. 23 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
31.05.2011
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy. Methods: Benzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus, A. flavus, A. terreus and Penicillium expansum, fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI). Results: Several benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho-hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae (sod1(delta), sod2(delta), glr1(delta)) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus (sakA(delta), mpkC(delta)), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes. Conclusions: Natural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments. |
---|---|
AbstractList | Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy.
Benzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus, A. flavus, A. terreus and Penicillium expansum, fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI).
Several benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho-hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae (sod1Δ, sod2Δ, glr1Δ) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus (sakAΔ, mpkCΔ), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes.
Natural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments. Background: Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy. Methods: Benzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus, A. flavus, A. terreus and Penicillium expansum, fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI). Results: Several benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho-hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae (sod1(delta), sod2(delta), glr1(delta)) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus (sakA(delta), mpkC(delta)), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes. Conclusions: Natural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments. BACKGROUND: Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy. METHODS: Benzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus, A. flavus, A. terreus and Penicillium expansum, fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI). RESULTS: Several benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho-hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae (sod1Δ, sod2Δ, glr1Δ) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus (sakAΔ, mpkCΔ), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes. CONCLUSIONS: Natural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments. BACKGROUNDDisruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy. METHODSBenzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus, A. flavus, A. terreus and Penicillium expansum, fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI). RESULTSSeveral benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho-hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae (sod1Δ, sod2Δ, glr1Δ) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus (sakAΔ, mpkCΔ), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes. CONCLUSIONSNatural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments. Abstract Background Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy. Methods Benzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus, A. flavus, A. terreus and Penicillium expansum, fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI). Results Several benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho-hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae (sod1Δ, sod2Δ, glr1Δ) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus (sakAΔ, mpkCΔ), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes. Conclusions Natural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments. Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy. Benzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus, A. flavus, A. terreus and Penicillium expansum, fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI). Several benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho-hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae (sod1[DELTA], sod2[DELTA], glr1[DELTA]) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus (sakA[DELTA], mpkC[DELTA]), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes. Natural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments. Abstract Background Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active compounds. Natural phenolic compounds can serve as potent redox cyclers that inhibit microbial growth through destabilization of cellular redox homeostasis and/or antioxidation systems. The aim of this study was to identify benzaldehydes that disrupt the fungal antioxidation system. These compounds could then function as chemosensitizing agents in concert with conventional drugs or fungicides to improve antifungal efficacy. Methods Benzaldehydes were tested as natural antifungal agents against strains of Aspergillus fumigatus , A. flavus , A. terreus and Penicillium expansum , fungi that are causative agents of human invasive aspergillosis and/or are mycotoxigenic. The yeast Saccharomyces cerevisiae was also used as a model system for identifying gene targets of benzaldehydes. The efficacy of screened compounds as effective chemosensitizers or as antifungal agents in formulations was tested with methods outlined by the Clinical Laboratory Standards Institute (CLSI). Results Several benzaldehydes are identified having potent antifungal activity. Structure-activity analysis reveals that antifungal activity increases by the presence of an ortho -hydroxyl group in the aromatic ring. Use of deletion mutants in the oxidative stress-response pathway of S. cerevisiae ( sod1 Δ, sod2 Δ, glr1 Δ) and two mitogen-activated protein kinase (MAPK) mutants of A. fumigatus ( sakA Δ, mpkC Δ), indicates antifungal activity of the benzaldehydes is through disruption of cellular antioxidation. Certain benzaldehydes, in combination with phenylpyrroles, overcome tolerance of A. fumigatus MAPK mutants to this agent and/or increase sensitivity of fungal pathogens to mitochondrial respiration inhibitory agents. Synergistic chemosensitization greatly lowers minimum inhibitory (MIC) or fungicidal (MFC) concentrations. Effective inhibition of fungal growth can also be achieved using combinations of these benzaldehydes. Conclusions Natural benzaldehydes targeting cellular antioxidation components of fungi, such as superoxide dismutases, glutathione reductase, etc ., effectively inhibit fungal growth. They possess antifungal or chemosensitizing capacity to enhance efficacy of conventional antifungal agents. Chemosensitization can reduce costs, abate resistance, and alleviate negative side effects associated with current antifungal treatments. |
ArticleNumber | 23 |
Audience | Academic |
Author | Campbell, Bruce C Kim, Jong H Chan, Kathleen L Mahoney, Noreen |
AuthorAffiliation | 1 Plant Mycotoxin Research Unit, Western Regional Research Center, USDA-ARS, 800 Buchanan St., Albany, CA 94710, USA |
AuthorAffiliation_xml | – name: 1 Plant Mycotoxin Research Unit, Western Regional Research Center, USDA-ARS, 800 Buchanan St., Albany, CA 94710, USA |
Author_xml | – sequence: 1 fullname: Kim, Jong H – sequence: 2 fullname: Chan, Kathleen L – sequence: 3 fullname: Mahoney, Noreen – sequence: 4 fullname: Campbell, Bruce C |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21627838$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kstr3DAQh01JaR7tubfW0ENPTjSyLWkvhU3oIxDooclZjOXRroLXSmU5ZPvXV47TJQspOoyY-enTvI6zg973lGXvgZ0CKHEGlRQFkwAFsIKXr7Kjnefg2f0wOx6GW8Y4Y0K-yQ45CC5VqY6y62UfnR37FXY5mujuXdzm3uaBWv9QPHoob6j_g11L621LQx7XGPOIYUUxN9R1Y4chx4TxD67FZPq32WuL3UDvnuxJdvPt6_XFj-Lq5_fLi-VV0QimYlFzRAsVE0hK1oAEloAIGlgYtIoBs7KWvGqoYTVryBhOzYIZgYqL2ojyJLucua3HW30X3AbDVnt0-tHhw0pjiM50pAURB2aoatqmAs7Sz7ZExkhVQoKUifVlZt2NzYZaQ30M2O1B9yO9W-uVv9clcCmrCXA-Axrn_wPYjxi_0dOE9DQhDUzzMkE-P2UR_O-Rhqg3bpiajD35cdBKVpXiC5hq_zQr0-RIu976BDWTWi-5YKCqBUy80xdU6bS0cSbtknXJv_fgbH5ggh-GQHZXQEpwWrkXUv7wvHE7_b8dS4KPs8Ci17gKbtA3vziDksGiTr2vy7-let2h |
CitedBy_id | crossref_primary_10_1007_s00253_017_8434_y crossref_primary_10_1038_s41598_020_74574_z crossref_primary_10_1016_j_micpath_2011_11_005 crossref_primary_10_3390_molecules18088873 crossref_primary_10_2520_myco_65_131 crossref_primary_10_1080_10408398_2017_1371112 crossref_primary_10_3390_mps2020031 crossref_primary_10_1155_2013_704654 crossref_primary_10_3390_app12094591 crossref_primary_10_3390_ijms22094520 crossref_primary_10_3390_molecules191118448 crossref_primary_10_1016_j_bbagen_2012_10_012 crossref_primary_10_1016_j_jhazmat_2023_131555 crossref_primary_10_1039_D1NP00022E crossref_primary_10_3390_app12083749 crossref_primary_10_1038_s41598_019_54679_w crossref_primary_10_1099_jmm_0_036145_0 crossref_primary_10_3390_foods10122993 crossref_primary_10_1007_s00253_021_11371_2 crossref_primary_10_1002_jccs_201200295 crossref_primary_10_1016_j_lwt_2022_113635 crossref_primary_10_1080_14786419_2017_1419228 crossref_primary_10_3389_fmicb_2024_1359947 crossref_primary_10_5012_bkcs_2012_33_8_2627 crossref_primary_10_2174_1570178616666181116100232 crossref_primary_10_3390_molecules24162971 crossref_primary_10_1016_j_ijbiomac_2022_02_077 crossref_primary_10_1155_2013_760754 crossref_primary_10_3390_microorganisms10020218 crossref_primary_10_1021_acs_chemrev_0c00586 crossref_primary_10_1016_j_pestbp_2019_06_015 crossref_primary_10_3390_plants9111416 crossref_primary_10_3390_molecules18021564 crossref_primary_10_1016_j_buildenv_2014_05_025 crossref_primary_10_3390_jof9111103 crossref_primary_10_1155_2020_6345429 crossref_primary_10_3390_mps7010001 crossref_primary_10_3390_foods10092073 crossref_primary_10_1021_acs_joc_9b01759 crossref_primary_10_3390_ijms13067375 crossref_primary_10_1080_01480545_2016_1188302 crossref_primary_10_1016_j_gaost_2021_03_002 crossref_primary_10_1111_jop_12735 crossref_primary_10_1007_s00294_014_0458_6 crossref_primary_10_1016_j_jprot_2018_09_016 crossref_primary_10_1021_acssuschemeng_7b00374 crossref_primary_10_1111_ijfs_15647 crossref_primary_10_1039_D3DT03229A |
Cites_doi | 10.1079/9781845930820.0000 10.1128/EC.00274-06 10.1128/AAC.50.3.949-954.2006 10.1128/MMBR.69.2.262-291.2005 10.1093/jac/dki473 10.1093/genetics/136.4.1261 10.1002/jps.10408 10.1002/yea.1636 10.1007/s10863-006-9012-7 10.1074/jbc.271.21.12275 10.1038/nrd3074 10.1073/pnas.011569399 10.1006/taap.2002.9417 10.1016/j.fgb.2004.11.002 10.1126/science.1118370 10.1177/153537020322800201 10.1023/B:MYCO.0000038430.20669.80 10.1016/0009-2797(85)90015-8 10.1046/j.1365-2958.2001.02384.x 10.1111/j.1365-2958.2004.04244.x 10.1104/pp.105.3.781 10.1053/jinf.2000.0747 10.1038/nbt919 10.1271/bbb.70051 10.1007/s11046-005-2877-x 10.1002/jcb.21741 10.1016/S0021-9258(18)32837-0 10.1039/b609523m 10.1016/j.bbrc.2008.05.030 10.1016/S0009-2797(99)00123-4 10.1093/jac/dkp273 10.1046/j.1365-2958.2001.02283.x 10.1128/AAC.00463-08 10.1128/EC.00178-06 10.1086/513943 10.1128/AAC.44.2.418-420.2000 10.1038/159850b0 10.1016/S1359-6446(99)01430-0 10.1093/jac/dkq031 10.1271/bbb.60.909 10.1128/iai.64.8.3326-3332.1996 10.1046/j.1365-280X.1999.00208.x 10.1002/ps.302 10.1128/aem.60.8.2811-2817.1994 10.1039/b914961a 10.1007/PL00012491 10.1016/S0006-291X(02)02290-8 10.1094/PHYTO-98-2-0205 10.1016/j.ijantimicag.2010.06.003 10.1128/iai.55.9.2088-2092.1987 10.1111/j.1472-765X.2011.03032.x 10.1128/AAC.00345-07 10.1128/AAC.50.2.744-747.2006 10.1128/EC.3.2.557-560.2004 10.1146/annurev.genet.39.073003.112634 10.7164/antibiotics.52.480 10.7164/antibiotics.57.511 10.1086/507891 10.1093/infdis/154.1.76 10.1016/S0925-4439(02)00085-6 10.1083/jcb.200104079 10.1016/S0891-5849(03)00210-7 10.1007/s00253-004-1821-1 10.1128/aem.63.7.2857-2862.1997 10.1007/s11046-010-9356-8 10.1128/AAC.48.4.1256-1271.2004 10.1105/tpc.12.2.237 10.1074/jbc.275.12.8290 10.4315/0362-028X-65.12.1937 10.1002/ps.263 10.1007/BF01575120 10.1002/bies.20020 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2011 BioMed Central Ltd. Copyright ©2011 Kim et al; licensee BioMed Central Ltd. 2011 Kim et al; licensee BioMed Central Ltd. |
Copyright_xml | – notice: COPYRIGHT 2011 BioMed Central Ltd. – notice: Copyright ©2011 Kim et al; licensee BioMed Central Ltd. 2011 Kim et al; licensee BioMed Central Ltd. |
DBID | FBQ CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1186/1476-0711-10-23 |
DatabaseName | AGRIS Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1476-0711 |
EndPage | 23 |
ExternalDocumentID | oai_doaj_org_article_6ee210ce4bdb4120aaff3a00e8467177 oai_biomedcentral_com_1476_0711_10_23 A260184913 10_1186_1476_0711_10_23 21627838 US201301957175 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GroupedDBID | --- -A0 23M 2VQ 2WC 3V. 4.4 53G 5GY 5VS 6J9 7X7 88E 8C1 8CJ 8FE 8FH 8FI 8FJ 8G5 AAFWJ AAJSJ ABUWG ABVAZ ACGFO ACGFS ACPRK ACRMQ ADBBV ADINQ ADRAZ AENEX AFGXO AFKRA AFNRJ AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS AZQEC BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BHPHI BMC BPHCQ BVXVI C1A C24 C6C CCPQU CS3 D1J DIK DWQXO E3Z EBD EBS ECGQY EJD EMB EMOBN F5P FBQ FYUFA GNUQQ GROUPED_DOAJ GUQSH GX1 HCIFZ HMCUK HYE IAO IGS IHR INH INR IPNFZ ITC KQ8 LK8 M1P M2O M48 M7P MM. M~E O5R O5S OK1 P2P PIMPY PQQKQ PROAC PSQYO RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB 0R~ ADUKV ALIPV CGR CUY CVF EBLON ECM EIF H13 NPM PGMZT AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-b608t-52aaf1406ae8751ae1fe1ee1b19caf8010f75724beb050becc2eb90c6a8265c63 |
IEDL.DBID | RPM |
ISSN | 1476-0711 |
IngestDate | Tue Oct 22 15:10:29 EDT 2024 Tue Sep 17 21:19:05 EDT 2024 Wed May 22 07:16:57 EDT 2024 Thu Aug 15 23:29:55 EDT 2024 Thu Feb 22 23:53:15 EST 2024 Wed Jan 10 04:07:43 EST 2024 Thu Sep 12 19:30:14 EDT 2024 Sat Sep 28 07:48:57 EDT 2024 Wed Dec 27 19:20:22 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b608t-52aaf1406ae8751ae1fe1ee1b19caf8010f75724beb050becc2eb90c6a8265c63 |
Notes | http://handle.nal.usda.gov/10113/53773 http://dx.doi.org/10.1186/1476-0711-10-23 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127747/ |
PMID | 21627838 |
PQID | 874482916 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_6ee210ce4bdb4120aaff3a00e8467177 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3127747 biomedcentral_primary_oai_biomedcentral_com_1476_0711_10_23 proquest_miscellaneous_874482916 gale_infotracmisc_A260184913 gale_infotracacademiconefile_A260184913 crossref_primary_10_1186_1476_0711_10_23 pubmed_primary_21627838 fao_agris_US201301957175 |
PublicationCentury | 2000 |
PublicationDate | 2011-05-31 |
PublicationDateYYYYMMDD | 2011-05-31 |
PublicationDate_xml | – month: 05 year: 2011 text: 2011-05-31 day: 31 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Annals of clinical microbiology and antimicrobials |
PublicationTitleAlternate | Ann Clin Microbiol Antimicrob |
PublicationYear | 2011 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | 11169096 - Mol Microbiol. 2001 Feb;39(3):533-41 3907866 - Chem Biol Interact. 1985 Dec 31;56(2-3):333-49 15075285 - Eukaryot Cell. 2004 Apr;3(2):557-60 20343980 - Nature. 1947 Jun 21;159(4051):850 10639374 - Antimicrob Agents Chemother. 2000 Feb;44(2):418-20 16983621 - Clin Infect Dis. 2006 Oct 15;43(8):1060-8 21332761 - Lett Appl Microbiol. 2011 May;52(5):506-13 8704323 - Biosci Biotechnol Biochem. 1996 May;60(5):909-10 11401713 - Mol Microbiol. 2001 Jun;40(5):1067-83 15888937 - Methods Mol Med. 2005;118:83-109 10722658 - J Biol Chem. 2000 Mar 24;275(12):8290-300 16349349 - Appl Environ Microbiol. 1994 Aug;60(8):2811-7 15702266 - Mycopathologia. 2004 Nov;158(4):419-26 20725094 - Nat Rev Drug Discov. 2010 Sep;9(9):719-27 15944456 - Microbiol Mol Biol Rev. 2005 Jun;69(2):262-91 10637546 - Drug Discov Today. 2000 Jan;5(1):25-32 12084464 - Biochim Biophys Acta. 2002 Jul 18;1587(2-3):224-33 3040589 - Infect Immun. 1987 Sep;55(9):2088-92 17341812 - Biosci Biotechnol Biochem. 2007 Mar;71(3):844-7 17119635 - Nat Prod Rep. 2006 Dec;23(6):851-63 16436735 - Antimicrob Agents Chemother. 2006 Feb;50(2):744-7 16449304 - J Antimicrob Chemother. 2006 Mar;57(3):384-410 20147322 - J Antimicrob Chemother. 2010 Apr;65(4):799-801 20485730 - Nat Prod Rep. 2010 Jul;27(7):1084-98 8013903 - Genetics. 1994 Apr;136(4):1261-9 17056742 - Eukaryot Cell. 2006 Dec;5(12):2184-8 18486603 - Biochem Biophys Res Commun. 2008 Jul 18;372(1):266-71 15057933 - Bioessays. 2004 Apr;26(4):348-62 11470816 - J Cell Biol. 2001 Jul 23;154(2):267-73 16195452 - Science. 2005 Sep 30;309(5744):2185-9 15341655 - Mol Microbiol. 2004 Sep;53(6):1785-96 15707841 - Fungal Genet Biol. 2005 Mar;42(3):200-12 14661025 - Nat Biotechnol. 2004 Jan;22(1):62-9 3519792 - J Infect Dis. 1986 Jul;154(1):76-83 20803256 - Mycopathologia. 2011 Apr;171(4):291-8 7749655 - Res Commun Mol Pathol Pharmacol. 1995 Feb;87(2):177-86 18395845 - J Cell Biochem. 2008 Aug 1;104(5):1747-59 15515888 - J Antibiot (Tokyo). 2004 Aug;57(8):511-7 18710914 - Antimicrob Agents Chemother. 2008 Nov;52(11):3851-62 12563018 - Exp Biol Med (Maywood). 2003 Feb;228(2):111-33 10480572 - J Antibiot (Tokyo). 1999 May;52(5):480-4 17053999 - J Bioenerg Biomembr. 2006 Apr;38(2):129-35 8647826 - J Biol Chem. 1996 May 24;271(21):12275-80 16495256 - Antimicrob Agents Chemother. 2006 Mar;50(3):949-54 20674282 - Int J Antimicrob Agents. 2010 Oct;36(4):324-31 9564455 - Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5 10647118 - Med Mycol. 1999 Dec;37(6):375-89 9212433 - Appl Environ Microbiol. 1997 Jul;63(7):2857-62 9735057 - Acta Microbiol Pol. 1998;47(1):45-53 11455660 - Pest Manag Sci. 2001 Mar;57(3):289-300 9063673 - Eur J Clin Microbiol Infect Dis. 1997 Jan;16(1):42-50 15614562 - Appl Microbiol Biotechnol. 2005 Jun;67(6):807-15 12884242 - J Pharm Sci. 2003 Aug;92(8):1545-58 12359231 - Biochem Biophys Res Commun. 2002 Oct 4;297(4):854-62 11120607 - J Infect. 2000 Nov;41(3):203-20 19656781 - J Antimicrob Chemother. 2009 Oct;64(4):764-73 11773615 - Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):144-9 8757871 - Infect Immun. 1996 Aug;64(8):3326-32 11374161 - Pest Manag Sci. 2001 May;57(5):437-42 6298224 - J Biol Chem. 1983 Mar 10;258(5):3107-13 12475174 - Cell Mol Life Sci. 2002 Oct;59(10):1640-8 16998074 - Eukaryot Cell. 2006 Nov;5(11):1934-40 12495013 - J Food Prot. 2002 Dec;65(12):1937-42 12788479 - Free Radic Biol Med. 2003 Jun 15;34(12):1599-606 10662860 - Plant Cell. 2000 Feb;12(2):237-48 15487314 - Mycopathologia. 2004 Jul;158(1):9-15 15568991 - Annu Rev Genet. 2004;38:725-48 18943197 - Phytopathology. 2008 Feb;98(2):205-14 12079430 - Toxicol Appl Pharmacol. 2002 Jun 15;181(3):209-18 10597903 - Chem Biol Interact. 1999 Nov 30;123(2):85-103 17576838 - Antimicrob Agents Chemother. 2007 Sep;51(9):3329-37 15047528 - Antimicrob Agents Chemother. 2004 Apr;48(4):1256-71 19061190 - Yeast. 2008 Nov;25(11):849-59 8058835 - Plant Physiol. 1994 Jul;105(3):781-6 CB Moore (227_CR4) 2000; 41 DE Levin (227_CR61) 2005; 69 CM Grant (227_CR24) 2001; 39 W Arafat (227_CR36) 1995; 87 K Fujita (227_CR21) 2004; 57 F Guillen (227_CR13) 1994; 60 PD Senter (227_CR52) 2002; 99 NJ Tonukari (227_CR41) 2000; 12 L Yan (227_CR76) 2009; 64 K Niimi (227_CR29) 2004; 48 DW Denning (227_CR31) 1998; 26 FM Ingels (227_CR50) 2003; 92 T Xue (227_CR43) 2004; 3 T Yamazaki (227_CR57) 2010; 36 T Florianowicz (227_CR11) 1998; 47 G Reyes (227_CR44) 2006; 5 JH McCusker (227_CR58) 1994; 136 S Tawata (227_CR10) 1996; 60 N Harris (227_CR19) 2003; 34 JH Kim (227_CR42) 2005; 67 T Motoyama (227_CR62) 2005; 42 M Sabater-Vilar (227_CR38) 2004; 158 W Arafat (227_CR35) 1985; 56 AR Holmes (227_CR7) 2008; 52 RG Washburn (227_CR17) 1987; 55 R Di Santo (227_CR3) 2010; 27 F Ruy (227_CR22) 2006; 38 AJ Hamilton (227_CR16) 1999; 37 N Ochiai (227_CR64) 2001; 57 J Lee (227_CR18) 2002; 297 M Goswami (227_CR25) 2006; 50 LE Cowen (227_CR68) 2006; 5 C Jacob (227_CR14) 2006; 23 MD Holdom (227_CR15) 1996; 64 R Fliege (227_CR33) 1999; 123 L Kanetis (227_CR65) 2008; 98 L Ostrosky-Zeichner (227_CR1) 2010; 9 JF Leslie (227_CR32) 2008 JH Kim (227_CR46) 2008; 372 J Meletiadis (227_CR49) 2007; 51 H Takimoto (227_CR2) 1999; 52 M Agarwal (227_CR12) 2001; 57 AB Parsons (227_CR40) 2004; 22 L McIntosh (227_CR78) 1994; 105 D Barrett (227_CR8) 2002; 1587 M Rep (227_CR53) 2000; 275 K Kojima (227_CR55) 2004; 53 D Michalkova-Papajova (227_CR20) 2000; 44 NCG Faria (227_CR77) 2011; 52 HD Isenberg (227_CR47) 1992 WB Pratt (227_CR71) 2003; 228 ML Sokol-Anderson (227_CR27) 1986; 154 JM Vincent (227_CR45) 1947; 159 TA Sangster (227_CR72) 2004; 26 MT Elskens (227_CR59) 1997; 63 JM Fostel (227_CR74) 2000; 5 R Mahfoud (227_CR34) 2002; 181 LE Cowen (227_CR67) 2005; 309 JC Young (227_CR69) 2001; 154 VD Longo (227_CR23) 1996; 271 I Maridonneau (227_CR54) 1983; 258 MA Schwartz (227_CR60) 2004; 38 EK Spanakis (227_CR6) 2006; 43 S Boisnard (227_CR66) 2008; 25 JR Graybill (227_CR26) 1997; 16 HO Byun (227_CR73) 2008; 104 M Rep (227_CR56) 2001; 40 JP Lavigne (227_CR30) 2010; 65 Y Okamoto (227_CR28) 2004; 158 MR Jacob (227_CR9) 2005; 118 JH Kim (227_CR51) 2011; 171 C Charlier (227_CR5) 2006; 57 JL McCallum (227_CR37) 2002; 65 227_CR39 D Picard (227_CR70) 2002; 59 G Chamilos (227_CR75) 2006; 50 Clinical and Laboratory Standards Institute (CLSI) (227_CR48) 2008 D Hagiwara (227_CR63) 2007; 71 |
References_xml | – volume-title: Mycotoxins: Detection Methods, Management, Public Health and Agricultural Trade year: 2008 ident: 227_CR32 doi: 10.1079/9781845930820.0000 contributor: fullname: JF Leslie – volume: 5 start-page: 2184 year: 2006 ident: 227_CR68 publication-title: Eukaryot Cell doi: 10.1128/EC.00274-06 contributor: fullname: LE Cowen – volume: 50 start-page: 949 year: 2006 ident: 227_CR25 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.50.3.949-954.2006 contributor: fullname: M Goswami – volume: 69 start-page: 262 year: 2005 ident: 227_CR61 publication-title: Microbiol Mol Biol Rev doi: 10.1128/MMBR.69.2.262-291.2005 contributor: fullname: DE Levin – volume: 57 start-page: 384 year: 2006 ident: 227_CR5 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dki473 contributor: fullname: C Charlier – volume: 47 start-page: 45 year: 1998 ident: 227_CR11 publication-title: Acta Microbiol Pol contributor: fullname: T Florianowicz – volume: 136 start-page: 1261 year: 1994 ident: 227_CR58 publication-title: Genetics doi: 10.1093/genetics/136.4.1261 contributor: fullname: JH McCusker – volume: 92 start-page: 1545 year: 2003 ident: 227_CR50 publication-title: J Pharm Sci doi: 10.1002/jps.10408 contributor: fullname: FM Ingels – volume: 25 start-page: 849 year: 2008 ident: 227_CR66 publication-title: Yeast doi: 10.1002/yea.1636 contributor: fullname: S Boisnard – volume: 38 start-page: 129 year: 2006 ident: 227_CR22 publication-title: J Bioenerg Biomembr doi: 10.1007/s10863-006-9012-7 contributor: fullname: F Ruy – volume: 271 start-page: 12275 year: 1996 ident: 227_CR23 publication-title: J Biol Chem doi: 10.1074/jbc.271.21.12275 contributor: fullname: VD Longo – volume: 9 start-page: 719 year: 2010 ident: 227_CR1 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd3074 contributor: fullname: L Ostrosky-Zeichner – volume: 99 start-page: 144 year: 2002 ident: 227_CR52 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.011569399 contributor: fullname: PD Senter – volume: 181 start-page: 209 year: 2002 ident: 227_CR34 publication-title: Toxicol Appl Pharmacol doi: 10.1006/taap.2002.9417 contributor: fullname: R Mahfoud – volume: 42 start-page: 200 year: 2005 ident: 227_CR62 publication-title: Fungal Genet Biol doi: 10.1016/j.fgb.2004.11.002 contributor: fullname: T Motoyama – volume: 309 start-page: 2185 year: 2005 ident: 227_CR67 publication-title: Science doi: 10.1126/science.1118370 contributor: fullname: LE Cowen – volume: 228 start-page: 111 year: 2003 ident: 227_CR71 publication-title: Exp Biol Med (Maywood) doi: 10.1177/153537020322800201 contributor: fullname: WB Pratt – volume: 158 start-page: 9 year: 2004 ident: 227_CR28 publication-title: Mycopathologia doi: 10.1023/B:MYCO.0000038430.20669.80 contributor: fullname: Y Okamoto – volume: 56 start-page: 333 year: 1985 ident: 227_CR35 publication-title: Chem Biol Interact doi: 10.1016/0009-2797(85)90015-8 contributor: fullname: W Arafat – ident: 227_CR39 – volume: 40 start-page: 1067 year: 2001 ident: 227_CR56 publication-title: Mol Microbiol doi: 10.1046/j.1365-2958.2001.02384.x contributor: fullname: M Rep – volume: 53 start-page: 1785 year: 2004 ident: 227_CR55 publication-title: Mol Microbiol doi: 10.1111/j.1365-2958.2004.04244.x contributor: fullname: K Kojima – volume: 105 start-page: 781 year: 1994 ident: 227_CR78 publication-title: Plant Physiol doi: 10.1104/pp.105.3.781 contributor: fullname: L McIntosh – volume: 41 start-page: 203 year: 2000 ident: 227_CR4 publication-title: J Infect doi: 10.1053/jinf.2000.0747 contributor: fullname: CB Moore – volume: 22 start-page: 62 year: 2004 ident: 227_CR40 publication-title: Nat Biotechnol doi: 10.1038/nbt919 contributor: fullname: AB Parsons – volume: 71 start-page: 844 year: 2007 ident: 227_CR63 publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.70051 contributor: fullname: D Hagiwara – volume: 158 start-page: 419 year: 2004 ident: 227_CR38 publication-title: Mycopathologia doi: 10.1007/s11046-005-2877-x contributor: fullname: M Sabater-Vilar – volume: 104 start-page: 1747 year: 2008 ident: 227_CR73 publication-title: J Cell Biochem doi: 10.1002/jcb.21741 contributor: fullname: HO Byun – volume: 258 start-page: 3107 year: 1983 ident: 227_CR54 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)32837-0 contributor: fullname: I Maridonneau – volume: 23 start-page: 851 year: 2006 ident: 227_CR14 publication-title: Natural Product Reports doi: 10.1039/b609523m contributor: fullname: C Jacob – volume: 372 start-page: 266 year: 2008 ident: 227_CR46 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2008.05.030 contributor: fullname: JH Kim – volume: 123 start-page: 85 year: 1999 ident: 227_CR33 publication-title: Chem Biol Interact doi: 10.1016/S0009-2797(99)00123-4 contributor: fullname: R Fliege – volume: 64 start-page: 764 year: 2009 ident: 227_CR76 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkp273 contributor: fullname: L Yan – volume: 39 start-page: 533 year: 2001 ident: 227_CR24 publication-title: Mol Microbiol doi: 10.1046/j.1365-2958.2001.02283.x contributor: fullname: CM Grant – volume: 52 start-page: 3851 year: 2008 ident: 227_CR7 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00463-08 contributor: fullname: AR Holmes – volume: 5 start-page: 1934 year: 2006 ident: 227_CR44 publication-title: Eukaryotic Cell doi: 10.1128/EC.00178-06 contributor: fullname: G Reyes – volume: 26 start-page: 781 year: 1998 ident: 227_CR31 publication-title: Clin Infect Dis doi: 10.1086/513943 contributor: fullname: DW Denning – volume: 44 start-page: 418 year: 2000 ident: 227_CR20 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.44.2.418-420.2000 contributor: fullname: D Michalkova-Papajova – volume: 159 start-page: 850 year: 1947 ident: 227_CR45 publication-title: Nature doi: 10.1038/159850b0 contributor: fullname: JM Vincent – volume: 5 start-page: 25 year: 2000 ident: 227_CR74 publication-title: Drug Discov Today doi: 10.1016/S1359-6446(99)01430-0 contributor: fullname: JM Fostel – volume: 65 start-page: 799 year: 2010 ident: 227_CR30 publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkq031 contributor: fullname: JP Lavigne – volume: 60 start-page: 909 year: 1996 ident: 227_CR10 publication-title: Biosci Biotechnol Biochem doi: 10.1271/bbb.60.909 contributor: fullname: S Tawata – volume: 64 start-page: 3326 year: 1996 ident: 227_CR15 publication-title: Infect Immun doi: 10.1128/iai.64.8.3326-3332.1996 contributor: fullname: MD Holdom – volume: 37 start-page: 375 year: 1999 ident: 227_CR16 publication-title: Med Mycol doi: 10.1046/j.1365-280X.1999.00208.x contributor: fullname: AJ Hamilton – volume: 57 start-page: 437 year: 2001 ident: 227_CR64 publication-title: Pest Manag Sci doi: 10.1002/ps.302 contributor: fullname: N Ochiai – volume: 60 start-page: 2811 year: 1994 ident: 227_CR13 publication-title: Appl Environ Microbiol doi: 10.1128/aem.60.8.2811-2817.1994 contributor: fullname: F Guillen – volume-title: Clinical Microbiology Procedures Handbook year: 1992 ident: 227_CR47 contributor: fullname: HD Isenberg – volume: 27 start-page: 1084 year: 2010 ident: 227_CR3 publication-title: Nat Prod Rep doi: 10.1039/b914961a contributor: fullname: R Di Santo – volume: 118 start-page: 83 year: 2005 ident: 227_CR9 publication-title: Methods Mol Med contributor: fullname: MR Jacob – volume: 59 start-page: 1640 year: 2002 ident: 227_CR70 publication-title: Cell Mol Life Sci doi: 10.1007/PL00012491 contributor: fullname: D Picard – volume: 297 start-page: 854 year: 2002 ident: 227_CR18 publication-title: Biochem Biophys Res Commun doi: 10.1016/S0006-291X(02)02290-8 contributor: fullname: J Lee – volume: 98 start-page: 205 year: 2008 ident: 227_CR65 publication-title: Phytopathology doi: 10.1094/PHYTO-98-2-0205 contributor: fullname: L Kanetis – volume: 36 start-page: 324 year: 2010 ident: 227_CR57 publication-title: Int J Antimicrob Agents doi: 10.1016/j.ijantimicag.2010.06.003 contributor: fullname: T Yamazaki – volume: 55 start-page: 2088 year: 1987 ident: 227_CR17 publication-title: Infect Immun doi: 10.1128/iai.55.9.2088-2092.1987 contributor: fullname: RG Washburn – volume: 52 start-page: 506 year: 2011 ident: 227_CR77 publication-title: Lett Appl Microbiol doi: 10.1111/j.1472-765X.2011.03032.x contributor: fullname: NCG Faria – volume: 51 start-page: 3329 year: 2007 ident: 227_CR49 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.00345-07 contributor: fullname: J Meletiadis – volume: 50 start-page: 744 year: 2006 ident: 227_CR75 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.50.2.744-747.2006 contributor: fullname: G Chamilos – volume: 3 start-page: 557 year: 2004 ident: 227_CR43 publication-title: Eukaryotic Cell doi: 10.1128/EC.3.2.557-560.2004 contributor: fullname: T Xue – volume: 38 start-page: 725 year: 2004 ident: 227_CR60 publication-title: Annu Rev Genet doi: 10.1146/annurev.genet.39.073003.112634 contributor: fullname: MA Schwartz – volume: 52 start-page: 480 year: 1999 ident: 227_CR2 publication-title: J Antibiot (Tokyo) doi: 10.7164/antibiotics.52.480 contributor: fullname: H Takimoto – volume: 57 start-page: 511 year: 2004 ident: 227_CR21 publication-title: J Antibiot (Tokyo) doi: 10.7164/antibiotics.57.511 contributor: fullname: K Fujita – volume: 43 start-page: 1060 year: 2006 ident: 227_CR6 publication-title: Clin Infect Dis doi: 10.1086/507891 contributor: fullname: EK Spanakis – volume: 154 start-page: 76 year: 1986 ident: 227_CR27 publication-title: J Infect Dis doi: 10.1093/infdis/154.1.76 contributor: fullname: ML Sokol-Anderson – volume: 87 start-page: 177 year: 1995 ident: 227_CR36 publication-title: Res Commun Mol Pathol Pharmacol contributor: fullname: W Arafat – volume-title: Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: Approved standard-Second edition. CLSI document M38-A2 year: 2008 ident: 227_CR48 contributor: fullname: Clinical and Laboratory Standards Institute (CLSI) – volume: 1587 start-page: 224 year: 2002 ident: 227_CR8 publication-title: Biochim Biophys Acta doi: 10.1016/S0925-4439(02)00085-6 contributor: fullname: D Barrett – volume: 154 start-page: 267 year: 2001 ident: 227_CR69 publication-title: J Cell Biol doi: 10.1083/jcb.200104079 contributor: fullname: JC Young – volume: 34 start-page: 1599 year: 2003 ident: 227_CR19 publication-title: Free Radic Biol Med doi: 10.1016/S0891-5849(03)00210-7 contributor: fullname: N Harris – volume: 67 start-page: 807 year: 2005 ident: 227_CR42 publication-title: Appl Microbiol Biotechnol doi: 10.1007/s00253-004-1821-1 contributor: fullname: JH Kim – volume: 63 start-page: 2857 year: 1997 ident: 227_CR59 publication-title: Appl Environ Microbiol doi: 10.1128/aem.63.7.2857-2862.1997 contributor: fullname: MT Elskens – volume: 171 start-page: 291 year: 2011 ident: 227_CR51 publication-title: Mycopathologia doi: 10.1007/s11046-010-9356-8 contributor: fullname: JH Kim – volume: 48 start-page: 1256 year: 2004 ident: 227_CR29 publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.48.4.1256-1271.2004 contributor: fullname: K Niimi – volume: 12 start-page: 237 year: 2000 ident: 227_CR41 publication-title: Plant Cell doi: 10.1105/tpc.12.2.237 contributor: fullname: NJ Tonukari – volume: 275 start-page: 8290 year: 2000 ident: 227_CR53 publication-title: J Biol Chem doi: 10.1074/jbc.275.12.8290 contributor: fullname: M Rep – volume: 65 start-page: 1937 year: 2002 ident: 227_CR37 publication-title: J Food Prot doi: 10.4315/0362-028X-65.12.1937 contributor: fullname: JL McCallum – volume: 57 start-page: 289 year: 2001 ident: 227_CR12 publication-title: Pest Manag Sci doi: 10.1002/ps.263 contributor: fullname: M Agarwal – volume: 16 start-page: 42 year: 1997 ident: 227_CR26 publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/BF01575120 contributor: fullname: JR Graybill – volume: 26 start-page: 348 year: 2004 ident: 227_CR72 publication-title: Bioessays doi: 10.1002/bies.20020 contributor: fullname: TA Sangster |
SSID | ssj0020067 |
Score | 2.1889064 |
Snippet | Background: Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with... Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with redox-active... Abstract Background Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved... Background Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with... BACKGROUNDDisruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with... BACKGROUND: Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved with... Abstract Background Disruption of cellular antioxidation systems should be an effective method for control of fungal pathogens. Such disruption can be achieved... |
SourceID | doaj pubmedcentral biomedcentral proquest gale crossref pubmed fao |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 23 |
SubjectTerms | Aldehydes animal pathogenic fungi antifungal agents Antifungal Agents - chemistry Antifungal Agents - pharmacology antifungal properties Antioxidants - chemistry Antioxidants - pharmacology Aspergillus flavus Aspergillus fumigatus Aspergillus terreus Benzaldehydes - chemistry Benzaldehydes - pharmacology Fungal Proteins - genetics Fungal Proteins - metabolism Fungi - drug effects Fungi - genetics Fungi - isolation & purification Fungi - metabolism Fungicides glutathione-disulfide reductase Health aspects Humans microbial growth mitogen-activated protein kinase mutants Mycoses - microbiology Oxidation-Reduction - drug effects Penicillium expansum phenolic compounds Saccharomyces cerevisiae Structure-Activity Relationship structure-activity relationships superoxide dismutase Superoxide Dismutase - genetics Superoxide Dismutase - metabolism yeasts |
SummonAdditionalLinks | – databaseName: BioMedCentral dbid: RBZ link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3PT90wDI4YaNIu08Z-0A2mHCZtl2pJ2iapdnpMIDQJLvAktEuUtM4eEupDo0jAX4_dljcCu03qqU6rNl8c2639mbHPorGtR1cCg5zoc_SI6zzE1uSh0LGOgFajouLkwyN9MC9_nlanf8miH_3Bl1Z_k6XRVGYzZF6p4hnbUMRxToH57q9VbEW77lBINA2eWHz-cYNHle3niUEaePvRzES_fLpHPzBSaQLlA4u0_4q9nFxJPhuxf83WoNtkz8fmkjdv2MmM8oBQl3EMVS9Qkwi-jJwYQq_z4QzwAN2tP29hcdPCJe8XvudjbjinL_qUoso95UNen429l96y-f7eyY-DfOqhkActbI8QeB8xiNIeMDKRHmQECSCDrBsf0TyJaCqjygBBVIIAVRBq0WiPcUfV6OIdW--WHWwxLoP1eJioNJS68FZ408pom0IZCSpm7Hsyse5i5MtwxGCdSlCZHMHiCBaHcYgqMvb1HobVhUOAYvXTobsEU3L_4QQuGzcpnNMAGM02UIY2lFIJnIZYeCGAHC5pTMa2EGTnf-Ne6ubHiv7gyrpCUZWxL4S8IxXHx238VKmA00BkWW5GNGy2rCU-yXYyElWzScT8fu04ElE-WwfLq0tHTQesQtc8Y-_HpbR6GyU1dT-xGTPJIkteN5V0Z4uBGLyQCr158-G_gPjIXozfzSlDYput93-uYAcdrz58GlTuDi0LKOg priority: 500 providerName: BioMedCentral – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOil9B23adCh0F5MJNmWZHraloQQSC_NQm5CskfdQPCGxoGkv74zlndZkUMvhT1ptIs1D8183nkw9kl0tvcYSiDIib7EiLgtQ-xNGSod2wjoNRoqTj7_oU-X9dllc7kz6otywlJ74MS4Iw2AqKSDOvShlkp4H2PlhQBynNKkOnLZbMDUDLXoEp7qioymEh05N_WRVh9t1-gGoilFWaH7deafpjb-6HWiXz--snd8Vp5PueOgTl6w53NkyRfpRC_ZExhesadp1uTDa3axoLQgNG3cQ8UMNDOCryOnhqH35bQCPMDwx1_3sHro4ZaPKz_ylCrO6QU_ZaxyT-mR91dpFNMbtjw5vvh-Ws4jFcqghR1RIsg_xFTaAwIV6UFGkAAyyLbzEb2ViKYxqg4QRCNIvgpCKzrtEYY0na7esr1hPcA-4zJYjx8TlYZaV94Kb3oZbVcpI0HFgn3NGOtuUvsMRw2tcwraliOxOBKLQ1iiqoJ92Yhh-8UJr1j9eOs3ElP2-9MCqpGb1cj9S40Kto9Cdv4XXq1u-VPRH7qybZDUFOwzSd6RxePjdn4uXEA2UO8st6CubLZuJT7JQbYTLbXLyHyjO45IlN42wPru1tEMAqswUi_Yu6RK29MoqWkYii2YyZQsO25OGa5WU5_wSioM7s37_8GfD-xZeptOeRMHbG_8fQcfMRwbw-FkeX8BwGoxAw priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3di9QwEA96Ivgifl_1lDwI-lJN0jZpEZFVPA7hfPEW7i0k7eT2YGl1twe7_vXOtL314h0IfeqkH8nMdObXzAdjr0VdNg5dCQQ5waXoEVepD41JfaZDFQCtRkHJycff9dE8_3ZanP5tBzQt4PpGaEf9pOar5bvNr-0nVPiPg8KX-r3MjaZEnCE2S2W32R2VZzmJ-3G-21Ig6Gym2j43XPRPvvsyMlNDNX80PsF117_cV0xXHFZ5xU4dPmD3JweTz0aJeMhuQfuI3R1bTm4fs5MZRQehhuMYymmg1hG8C5zqhm7S4QxwD-1vt2xgsW1gzfuF6_kYMc7pPz8FrnJHUZKb87Ej0xM2P_x68uUonTorpF6LskfGOBcQWmkHiFekAxlAAkgvq9oFNFoimMKo3IMXhSA2K_CVqLVDNFLUOnvK9tquhX3GpS8dHiYoDbnOXCmcaWQo60wZCSok7EO0sPbnWEXDUl3rmIIqZoktlthiEZ2oLGFvL9mwu3CALaW-PvQzsSm6_3CiW53ZSQ2tBkCMW0PuG59LJXAZQuaEAHLDpDEJ20cmW3eGX1g7_6FoX1dWBZKKhL0hzlsSRXzd2k35C7gMVELLzqg4W5lXEt_kIBqJCltHZH4pO5ZIFOXWQnexttSKoFTosCfs2ShKu9koqaknSpkwEwlZNN2Y0p4vhnLhmVTo45vn_3_sC3Zv_GVOwREHbK9fXcBL9Ll6_2rQpT8ymCqO priority: 102 providerName: Scholars Portal |
Title | Antifungal activity of redox-active benzaldehydes that target cellular antioxidation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21627838 https://search.proquest.com/docview/874482916 http://dx.doi.org/10.1186/1476-0711-10-23 https://pubmed.ncbi.nlm.nih.gov/PMC3127747 https://doaj.org/article/6ee210ce4bdb4120aaff3a00e8467177 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swEBdtx2AvZd_12gU_DLYXN5ZsSzJ7SkJLGaSUroGwFyHZpyaQOqVNod1f3zt_lHp9Gxg9-GQj63S6O_l3d4x9iwtdWjQl0MnxNkKLOI-cL1XkEulzD6g1MgpOnp7Kk1n6a57Nt1jWxcLUoP3CLQ-r1dVhtVzU2Mrrq2LY4cSGZ9NJwgVaLWq4zbZVknQueutl0f7b5vDhWg55qiRF6dTALZHUyX8llZfQ_4S4r3qaqU7gj_rG2_XLzfqZtuojKZ-ppuO3bLe1KcNRM_Z3bAuq9-x1U2Xy4QO7GBEgCIUa-1AYA1WLCNc-pFSh91F9B0IH1V-7KmHxUMJtuFnYTdiAxEM62iesamgJGHm_bIowfWSz46OLyUnUFlOInIz1BnlhrUdvSlpAF4Vb4B44AHc8L6xHPRV7lSmROnBxFhNnBbg8LqRFByQrZPKJ7VTrCvZYyJ22eCkvJKQysTq2quReF4lQHIQP2M_exJrrJnGGoVTWfQpKlSEOGeKQQYdEJAH70bHh6cHaU9HyZdcxsan3_vrG-ubStAvGSAB0awtIXelSLmKcBp_YOAayvLhSAdtDJht7iZuqmf0W9CuX5xmSsoB9J84bknUcbmHbkAWcBsqaZUaUj02nOceRHPR6oowWPXLYrR1DJAK2VbC-uzVUfUALtNED9rlZSk9f063TgKneIut9bp-CAlNnCG8F5Mt_P7nP3jSH5wSTOGA7m5s7-IrW18YNUObmCls94QP2anx0enY-qE8ysJ2mGtvz8Z9BLZOP5sQ1hA |
link.rule.ids | 108,230,315,733,786,790,870,891,2115,2236,24346,24965,27955,27956,31753,33300,33778,53825,53827,76167,76168 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VIgQX3qUuBXxAgosT79pe2-IUKqoATYVEgnpb7a5nm4jUqVpHavvrO-NHVbcnkHzyrC2v521_M8PYx9BmhcZQApMcpwOMiPPAuCINTCRd7gC9RkLFyZNDOZ7FP46Sow2WdLUwNWjfmsWgXJ4MysW8xlaenthhhxMb_prsRVxg1JIOH7CHqK8i6ZL0Ns8iC9x28eGZHPI4lVSnU0O3RFS3_5U0YCK7U-S-7PmmuoU_ehynV_fN9S1_1cdS3nJO-8_Yn25bDSbl72BdmYG9utPx8Z_3_Zw9bcNVf9SQX7ANKF-yR80Ay8tXbDoirBHaC1xDFRI0iMJfOZ-6kF4E9RnwDZRXelnA_LKAc7-a68pv8Oc-_TUgGKyvCXN5sWjmO71ms_1v071x0M5pCIwMswrZrLXDRE1qwOyHa-AOOAA3PLfaoQsMXZqkIjZgwiQkoRFg8tBKjblNYmW0xTbLVQnbzOcm03ikTkiIZaSzUKcFd5mNRMpBOI996XFMnTY9ORR1ye5TUGEVsV4R6xXmOiLy2OeOvzcX1klQJu8v_Ur8792_PrE6O1YtT5QEwIzZQmwKE3MR4mtwkQ5DoKCOp6nHtlF6lD5Ge61mvwX9JeZ5gqTEY59IpBSZEXxcq9tqCHwN1JBLjajVWxbnHJ9kt7cS1d_2yH4nlIpIhJkrYbU-VzTYIBMY_nvsTSOjN7vpFMBjaU96e9vtU1Am6-bjrQzu_PeVH9jj8XRyoA6-H_58y5403-gJjbHLNquzNbzDIK8y72uVvgbGBFFN |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELZaqla99E0JpW0OldpLdmMnsRP1tKVd0QcIqayEerHsZMyuumRXkJWAX89MHmgDN6ScYieKM-OZ-ZJvZhj7FOZpYTCUQJDjTIARcRZYV6jARtJlDtBrJJScvH8g9ybxr-PkeK3VV03az-1sUM5PB-VsWnMrl6f5sOOJDQ_3dyMuMGpRw2Xhhg_ZI9yzQnVAvcVaZIXbSj48lUMeK0m5OjV9S0R1CWBJTSbSW4nu855_qsv4o9dxZnHXZK_5rD6fcs1BjZ-zf93SGl7K_8GqsoP86lbVx3ut_QV71oat_qiZ8pI9gPIVe9w0srx8zY5GxDlCu4FzKFOCGlL4C-dTNdKLoD4DvoXyyswLmF4WcO5XU1P5DQ_dp78HRIf1DXEvL2ZNn6c3bDL-cbS7F7T9GgIrw7RCcRvjELBJA4iCuAHugANwy7PcOHSFoVOJErEFGyYhKY8Am4W5NIhxklxGm2yjXJSwxXxuU4OHckJCLCOThkYV3KV5JBQH4Tz2tSc1vWxqc2iqlt0fwY2rSfyaxK8R84jIY186Gd9cWIOhVN6d-o10oHf_-sTi7ES3ctESAJFzDrEtbMxFiK_BRSYMgYI7rpTHtlCDtDlBu60nfwX9LeZZgkOJxz6TWmkyJ_i4uWmzIvA1UGEuPaKSb2mccXySnd5MNAN5b9jvFFPTEHHnSliszjU1OEgFwgCPvW309GY13SbwmOppcG-5_RHUy7oIeauH2_e-8iN7cvh9rP_8PPj9jj1tPtUTKWOHbVRnK3iPsV5lP9S7-ho4HFPN |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antifungal+activity+of+redox-active+benzaldehydes+that+target+cellular+antioxidation&rft.jtitle=Annals+of+clinical+microbiology+and+antimicrobials&rft.au=Kim%2C+Jong+H&rft.au=Chan%2C+Kathleen+L&rft.au=Mahoney%2C+Noreen&rft.au=Campbell%2C+Bruce+C&rft.date=2011-05-31&rft.eissn=1476-0711&rft.volume=10&rft.spage=23&rft.epage=23&rft_id=info:doi/10.1186%2F1476-0711-10-23&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1476-0711&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1476-0711&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1476-0711&client=summon |